APA (7th ed.) Citation

Younossi, Z. M., Paik, J. M., Henry, L., Pollock, R. F., Stepanova, M., & Nader, F. Economic evaluation of non-invasive test pathways for high-risk metabolic dysfunction-associated steatotic liver disease (MASLD) in the United Kingdom (UK). Elsevier.

Chicago Style (17th ed.) Citation

Younossi, Zobair M., James M. Paik, Linda Henry, Richard F. Pollock, Maria Stepanova, and Fatema Nader. Economic Evaluation of Non-invasive Test Pathways for High-risk Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in the United Kingdom (UK). Elsevier.

MLA (9th ed.) Citation

Younossi, Zobair M., et al. Economic Evaluation of Non-invasive Test Pathways for High-risk Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in the United Kingdom (UK). Elsevier.